Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk (NYSE: NVO) started the GLP-1 weight-loss revolution that is sweeping the world. Its Wegovy/Ozempic shot was…
Taking the new Wegovy pill every day is really complicated. Will patients stick with it?
Last Updated: Feb. 11, 2026 at 8:59 a.m. ETFirst Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled…
Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead – MarketWatch
Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead MarketWatch What…